About Atc Pharma Private Limited
Data last updated:
Atc Pharma Private Limited was a private limited company based in Hyderabad, Telangana, India, operated as a subsidiary of Dhruvi Pharma Private Limited. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 January 2019.
The company was registered with the Registrar of Companies (ROC), Hyderabad, under CIN U51909TS2019PTC173351. Its GSTIN is 24AARCA8274C1ZJ (Gujarat).
The company had an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It was led by directors including Firoz Patel and Sabir Mohmadbhai Patel.
Its last annual general meeting (AGM) was held on 31 August 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹206.78 Cr, a decline of 5% compared to the previous year. For the same year it recorded a net loss of ₹1.97 Cr (net margin -1%) and EBITDA of ₹4.18 Cr (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years.
The company had about 30 employees on its provident fund (EPFO) records before it was dissolved. Its group structure included 1 subsidiary.
As per MCA filings, the company had satisfied charges of ₹36 Cr on record. Court records list 13 cases involving the company, including 12 filed by the company and 1 filed against it; 5 cases are pending. The company has 2 deals on record (2 rights issues); the latest was in May 2019. Its 6 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 2 smaller; the largest is Shreeji Distributors Pharma Private Limited with revenue of ₹214.34 Cr.
The last known website on record is atc-pharma-pvt-ltd.business.site.
Company details
CIN history
Atc Pharma has one previous CIN (Corporate Identification Number): U51909GJ2019PTC106215. The current CIN is U51909TS2019PTC173351, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U51909TS2019PTC173351 | Current |
| U51909GJ2019PTC106215 | Previous |
Contact details
Atc Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is atc-pharma-pvt-ltd.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressD.No. 7 – 2 – 1740 K.Subbaiah Pillai Godowns, Main Road Sanath Nagar, Hyderabad, Telangana, India – 500018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Atc Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Atc Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Atc Pharma Private Limited, buy the company report.
Financials of Atc Pharma Private Limited
FY 2023 filings availableAtc Pharma Private Limited reported revenue of ₹206.78 Cr (down 5% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 5% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹206.78 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.97 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | -1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Atc Pharma Private Limited, buy the company report.
Board of directors of Atc Pharma Private Limited
Atc Pharma has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arvind Kumar Venkat | Nominee Director | 18 May 2019 | 7 Years 5 Months | As last reported |
| Rupesh Hemendra Shah Also directs: Relicorp Logistics LLP, Meditree Lifecare LLP, Yashvi Distribution Services Private Limited and 5 more | Nominee Director | 18 May 2019 | 7 Years 5 Months | As last reported |
| Firoz Patel Also directs: Atc Medicare Private Limited, Allied Healthcare Private Limited | Director | 22 Jan 2019 | 7 Years 9 Months | As last reported |
| Sabir Mohmadbhai Patel Also directs: Allied Healthcare Private Limited | Director | 22 Jan 2019 | 7 Years 9 Months | As last reported |
Peer comparison
Atc Pharma Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shreeji Distributors Pharma Private Limited | ₹214.34 Cr (FY 2025) | 5.0% | Mumbai, Maharashtra, India | |||
| Gobinda Distributors Private Limited | ₹212.92 Cr (FY 2025) | 15.0% | Kolkata, West Bengal, India | |||
| Rahul Distributors Private Limited | ₹212.41 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Shree Amman Pharma India Private Limited | ₹210.32 Cr (FY 2025) | 12.0% | Chennai, Tamil Nadu, India | |||
| Atc Pharma Private Limitedthis company | ₹206.78 Cr (FY 2023) | -₹1.97 Cr | -1% | -5.0% | 30 | Hyderabad, Telangana, India |
| Kunal Pharma Distributors Private Limited | ₹203.36 Cr (FY 2025) | 39.0% | Secunderabd, Telangana, India | |||
| Umang Cure Private Limited | ₹203.3 Cr (FY 2025) | 14.0% | New Delhi, Delhi, India |
To see the full peer comparison of Atc Pharma Private Limited, buy the company report.
Auditor
Atc Pharma Private Limited is audited by VCAN AND CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VCAN AND CO | FY 2023 | 125172W |
Shareholding
The shareholding of Atc Pharma Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Atc Pharma Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Aug 2019 | 100285756 | Hdfc Bank Limited | ₹36 Cr | Satisfied |
To see the full charge records of Atc Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Deals & funding
Atc Pharma Private Limited has 2 deals on record (2 rights issues); the latest was in May 2019.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| May 2019 | Rights issue | ₹12 Cr | Investors: Dhruvi Pharma Private Limited , Keimed Private Limited , an individual |
| Mar 2019 | Rights issue | ₹19 Lakh | Investors: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Atc Pharma Private Limited has 13 court cases on record: 12 filed by Atc Pharma, 1 filed against it. 5 cases are pending and 8 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 11 | 1 | 5 |
| NCLT | 2 | 0 | 0 |
Cases on record (5 of 13)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Civil suit | Filed against the company by M/S Morepen RX Limited | Disposed |
| District court, Vadodara, Gujarat | Criminal miscellaneous application | Filed by the company against First Cure Pharmaceuticals Proprietor Arpitaben Amitkumar Patel | Pending |
| District court, Vadodara, Gujarat | Criminal complaint | Filed by the company against an individual | Pending |
| District court, Vadodara, Gujarat | Court case (SMST S) | Filed by the company against an individual | Pending |
| District court, Vadodara, Gujarat | Court case (SMST S) | Filed by the company against Kayush Lab Pvt.Ltd., and 2 others | Pending |
To see the full case history of Atc Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Atc Pharma Private Limited was last rated by Care on 07 Oct 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Care | 07 Oct 2022 |
To see the full credit ratings and regulatory alerts of Atc Pharma Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Atc Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Atc Pharma has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Atc Medicare Private Limited | U51909GJ2022PTC130084 |
To see the full group structure of Atc Pharma Private Limited, buy the company report.
Employees & EPFO
Atc Pharma Private Limited has a workforce of 30 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Atc Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AARCA8274C1ZJ | Gujarat | Active | 28 Jan 2019 |
To see the full GST registrations and return filing status of Atc Pharma Private Limited, buy the company report.
Recent activity
Atc Pharma Private Limited has 6 board changes on record since 2019: 4 appointments and 2 cessations. The latest: Arvind Kumar Venkat ceased to be Nominee Director on 20 Mar 2023.
Frequently asked questions
Atc Pharma has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Atc Pharma was a private limited company based in Hyderabad, Telangana, India. The company worked in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 January 2019 and is registered under CIN U51909TS2019PTC173351. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Atc Pharma was incorporated on 22 January 2019. It is registered with the Registrar of Companies, Hyderabad.
Atc Pharma had 4 directors:
- Arvind Kumar Venkat - Nominee Director
- Rupesh Hemendra Shah - Nominee Director
- Firoz Patel - Director
- Sabir Mohmadbhai Patel - Director
The CIN (Corporate Identification Number) of Atc Pharma is U51909TS2019PTC173351. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Atc Pharma is at D.No. 7 – 2 – 1740 K.Subbaiah Pillai Godowns, Main Road Sanath Nagar, Hyderabad, Telangana, India – 500018.
Atc Pharma can be reached through the website atc-pharma-pvt-ltd.business.site. Its registered office is in Hyderabad, Telangana, India.
The latest financial statements of Atc Pharma on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 31 August 2023. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Atc Pharma is 24AARCA8274C1ZJ, registered in Gujarat.
Atc Pharma operated in the pharma industry, in the pharmaceutical retailers and distributors segment.
Atc Pharma has 2 deals on record (2 rights issues); the latest was in May 2019.